Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2018 - Volume 22, Number 1
View All Articles in Issue

Page(s):  55

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $65

Abstract:  A formulation for preparing Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, penicillamine-D, chelating agent, heavy metals, rheumatoid arthritis, cystinuria, primary biliary cirrhosis, scleroderma, Wilson disease, copper poisoning, lead poisoning

Related Categories: EXCIPIENTS, FORMULATIONS, GASTROENTEROLOGY, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 55

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Stein Michael F
, Parsons Eric
Jul/Aug 2003
Pg. 272-275

Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Allen Loyd V Jr
Jan/Feb 2020
Pg. 38-43

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

The Treatment of Canine Atopic Disease
Davidson Gigi S
May/Jun 2002
Pg. 210-215

Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC
, Loures S, Lima LC, Ferreira AO, Brandão MA
Mar/Apr 2016
Pg. 167-174

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 493

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions